News

Capital increase

New fully paid-up share capital: CHF 100,000 divided into 100,000 registered shares of CHF 1, with transfer restrictions as per the Articles of Association. Ordinary capital increase, in cash and by o…

Board Composition

Mr. Jan Van den Berghe is appointed as new member of the Board of Alithea Genomics SA.

Board Composition

Mr. Roger Küng is appointed as new member of the Board of Alithea Genomics SA.

Board Composition

Mr. Hans Binz is appointed as new member of the Board of Alithea Genomics SA.

Financing

The share capital of Alithea Genomics SA is increased to CHF 144,294, divided into 100,000 registered common shares of CHF 1 and 44,294 preferred registered shares as to liquidation proceeds of CHF 1,…

Alithea Genomics SA
16 December 2021

Board Composition

M. Riccardo Dainese is stepping down as Chairman of the Board and Frederik Decouttere is taking over the role.

Alithea Genomics SA
16 August 2021

Board Composition

Mr. Bart Deplancke is no longer member of the Board of Directors of Alithea Genomics SA.

Board Composition

Mr. Riccardo Dainese is appointed as new Chairman of the Board of Alithea Genomics SA.

Board Composition

Mr. Daniel Alpern is appointed as new member of the Board of Alithea Genomics SA.

Board Composition

Mr. Bart Deplancke is appointed as new member of the Board of Alithea Genomics SA.

Incorporation

Alithea Genomics SA is registered in the Commercial Register of the canton of Vaud with a share capital of CHF 100,000, which is partially paid-in, divided into 100,000 common registered shares of CHF…